1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Vitamin A Defficiency Disorders Global Clinical Trials Review, H2, 2015

Vitamin A Defficiency Disorders Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Vitamin A Defficiency Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Vitamin A Defficiency Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Vitamin A Defficiency Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Vitamin A Defficiency Disorders Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Vitamin A Defficiency Disorders to Nutritional Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 16
Clinical Trials by E7 Countries: Proportion of Vitamin A Defficiency Disorders to Nutritional Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Vitamin A Defficiency Disorders Therapeutics Clinical Trials 28
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Disclaimer 54
Source 55

List of Tables
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials by Region, 2015* 5
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 9
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Europe, Top Countries, 2015* 10
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 12
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
Proportion of Vitamin A Defficiency Disorders to Nutritional Disorders Clinical Trials, G7 Countries (%), 2015* 15
Vitamin A Defficiency Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Proportion of Vitamin A Defficiency Disorders to Nutritional Disorders Clinical Trials, E7 Countries (%), 2015* 17
Vitamin A Defficiency Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Vitamin A Defficiency Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Vitamin A Defficiency Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List of Figures
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials by Region (%), 2015* 5
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 9
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 10
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 12
Proportion of Vitamin A Defficiency Disorders to Nutritional Disorders Clinical Trials, G7 Countries (%), 2015* 14
Vitamin A Defficiency Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Proportion of Vitamin A Defficiency Disorders to Nutritional Disorders Clinical Trials, E7 Countries (%), 2015* 17
Vitamin A Defficiency Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Vitamin A Defficiency Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Vitamin A Defficiency Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Vitamin A Defficiency Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Vitamin A Defficiency Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 53

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Global Clinical Trials Market

Global Clinical Trials Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) ...

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trial Management System Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The Global market for Clinical Trial Management System is expected to reach $2 billion by the end of 2020 growing at a CAGR of around 12.5% from 2014 to 2021. Clinical Trial Management System is a system ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.